These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

939 related articles for article (PubMed ID: 19482349)

  • 1. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy.
    Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
    J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of hyposensitization with bee and wasp venom].
    Adolph J; Dehnert I; Fischer JF; Wenz W
    Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.
    Roumana A; Pitsios C; Vartholomaios S; Kompoti E; Kontou-Fili K
    J Allergy Clin Immunol; 2009 Aug; 124(2):379-81. PubMed ID: 19560804
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for Hymenoptera venom allergy compared with real-life stings: Are we doing our best?
    Pecoraro L; Giovannini M; Mori F; Saretta F; Barni S; Castagnoli R; Arasi S; Mastrorilli C; Liotti L; Caminiti L; Novembre E;
    Clin Exp Allergy; 2021 Feb; 51(2):209-211. PubMed ID: 33617014
    [No Abstract]   [Full Text] [Related]  

  • 6. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
    Carballada F; Boquete M; Núñez R; Lombardero M; de la Torre F
    J Investig Allergol Clin Immunol; 2010; 20(6):506-13. PubMed ID: 21243935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
    Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy.
    Ruëff F; Bilò MB; Jutel M; Mosbech H; Müller U; Przybilla B;
    J Allergy Clin Immunol; 2009 Jan; 123(1):272-3; author reply 273. PubMed ID: 19130944
    [No Abstract]   [Full Text] [Related]  

  • 9. Initiating yellow jacket venom immunotherapy with a 100-μg dose: A challenge?
    Vos BJPR; Dubois AEJ; Rauber MM; Pfützner W; Miehe M; Bohle B; Möbs C; Oude Elberink JNG
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1332-1334.e4. PubMed ID: 30240885
    [No Abstract]   [Full Text] [Related]  

  • 10. The sting challenge test in Hymenoptera venom allergy: pros and cons.
    Bilò MB; Brianzoni MF; Garritani MS; Antonicelli L; Farabollini B; Bonifazi F
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):377-81. PubMed ID: 14768522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stinging insect allergy and venom immunotherapy.
    Gupta P; Greenberger PA
    Allergy Asthma Proc; 2004; 25(4 Suppl 1):S9-10. PubMed ID: 15515364
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged interval immunotherapy of Hymenoptera sting allergy.
    Barr SE
    Ann Allergy; 1976 May; 36(5):308-12. PubMed ID: 937769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
    Nittner-Marszalska M; Cichocka-Jarosz E; Małaczyńska T; Kraluk B; Rosiek-Biegus M; Kosinska M; Pawłowicz R; Lis G
    J Investig Allergol Clin Immunol; 2016; 26(1):40-7. PubMed ID: 27012015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.
    Bernstein JA; Kagen SL; Bernstein DI; Bernstein IL
    Ann Allergy; 1994 Nov; 73(5):423-8. PubMed ID: 7978535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venom immunotherapy (VIT): clinical efficacy and improvement in quality of life.
    Oude Elberink J
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():43-5. PubMed ID: 19221618
    [No Abstract]   [Full Text] [Related]  

  • 16. [Allergy to Hymenoptera].
    Beretta E
    Rev Med Suisse Romande; 1986 Sep; 106(9):801-8. PubMed ID: 2877485
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of specific IgG4 in allergy].
    Sabbah A; Lebricon T; Penn P; Vassal V; Heulin MG
    Allerg Immunol (Paris); 1987 Sep; 19(7):268-81. PubMed ID: 2455528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute polyradiculoneuropathy occurring after hymenoptera stings: a clinical case study.
    Ridolo E; Albertini R; Borghi L; Meschi T; Montanari E; Dall'Aglio PP
    Int J Immunopathol Pharmacol; 2005; 18(2):385-90. PubMed ID: 15888260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which immunotherapy product is better for patients allergic to Polistes venom? A laboratory and clinical study.
    Savi E; Incorvaia C; Boni E; Mauro M; Peveri S; Pravettoni V; Quercia O; Reccardini F; Montagni M; Pessina L; Ridolo E
    PLoS One; 2017; 12(7):e0180270. PubMed ID: 28686638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.